Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJF6Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,037
Award facts
- Contract value 100% obligated
- $44,036.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $44,036.81 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Dupixent 200 mg/1.14 mL pens. This is a non-set-aside, competitively awarded contract with a completion date of December 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, asthma, and eosinophilic conditions, making this a specialized pharmaceutical procurement supporting federal healthcare needs.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a diverse range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare systems and other federal customers, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical vendor in the federal medical supply chain, AmerisourceBergen has demonstrated consistent capability to fulfill competitive federal procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FJF6Q?
SPE2DR26FJF6Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FJF6Q worth?
The government has obligated $44,037 on SPE2DR26FJF6Q.
Is contract SPE2DR26FJF6Q an order under another contract?
Yes. SPE2DR26FJF6Q is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJF6Q competed?
The extent of competition for SPE2DR26FJF6Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award